Section Arrow
VOR.NASDAQ
- Vor Biopharma Inc
Quotes are at least 15-min delayed:2025/11/20 22:03 EST
Regular Hours
Last
 6.86
-0.96 (-12.28%)
Day High 
8.16 
Prev. Close
7.82 
1-M High
30.4 
Volume 
1.09M 
Bid
6.88
Ask
7.1
Day Low
6.5 
Open
7.82 
1-M Low
7.76 
Market Cap 
148.79M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 12.31 
20-SMA 18.58 
50-SMA 27.17 
52-W High 65.8 
52-W Low 2.622 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-273.60/-7.67
Enterprise Value
176.41M
Balance Sheet
Book Value Per Share
-116.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.85-0.18-4.47%-- 
CYPHCypherpunk Technologies Inc.2.94--0.000%-- 
PSTVPlus Therapeutics0.4884-0.0017-0.35%-- 
ASBPAspire Biopharma Holdings Inc.0.0977-0.0015-1.51%-- 
PBMPsyence Biomedical Ltd1.72-1.07-38.35%0.07PE
Quotes are at least 15-min delayed:2025/11/20 22:03 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.